Gut Microbiome: Current Status and Future Perspectives

Dear Colleagues,

Gut microbiota are now considered as one of the key elements contributing to the regulation of host health. Because of the development of molecular tools and techniques, the complex interactions between the host and the different microorganisms are progressively being deciphered. Gut microbiota deviations are linked with many diseases including obesity, type 2 diabetes, hepatic steatosis, intestinal bowel diseases (IBDs) and several types of cancer. Thus, this suggests that various pathways involved in immunity and the energy, lipid and glucose metabolisms are affected. Moreover, scientists have identified that the gut microbiome contributes not only to the health and diseases of the gut itself, but also to those remote extra-enteric organs such as the liver, brain, skin, heart, muscle and bone via a bidirectional signaling process. With the rapid development of gut microbiome research and the increase in up-to-date knowledge, the monitoring of the host microbiome has become an emerging area of diagnostics for personalized medicine. We believe that the advances in our understanding of the gut microbiota will greatly transform our way of life in the next decade. I invite colleagues and health professionals in basic, clinical and field research to submit their manuscripts to this Special Issue in the form of original research studies and reviews.

Dr. Vlasta Demeckova
Dr. Petra Hradicka
Dr. Dagmar Mudronova
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.